gip glp 1 agonist tirzepatide Main physiological actions of the dual and GLP-1 Understand GLP-1/GIP Dual Agonist Tirzepatide

SGLT2 inhibitors are preferred in people with HF or at high-risk for HF, whereas GLP-1 receptor agonists are favored for those requiring significant weight loss, ASCVD risk reduction, CKD management, or in whom mitigation of metabolic dysfunction-associated steatotic liver disease (MASLD) or steatohepatitis is a clinical priority [84]

Peak Wellness operates through a four-step system designed to get medication to your door as fast as possible, and they have stripped away nearly every barrier that traditional weight loss clinics put in front of patients

What this means for your CGM data: Because GLP-1 drugs slow gastric emptying, they blunt the sharp post-meal glucose spikes that are hardest for insulin to catch

However, the use of this medication requires a prolonged initial treatment period of dose-escalation to attenuate the adverse gastrointestinal effects (nausea, vomiting, diarrhea) typically associated with GLP-1R agonists, which still occurred frequently but rarely resulted in discontinuation of treatment

Khaleel MA, Khan AH, Ghadzi SMS, Adnan AS, Abdallah QM